Herbal preparations for obesity: are they useful? (Q35563450)

8 August 2017

1 reference

title

Herbal preparations for obesity: are they useful? (English)

1 reference

8 August 2017

0 references

David Heber

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567158

22 March 2024

publication date

1 June 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0095454303000150?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

https://api.elsevier.com/content/article/PII:S0095454303000150?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Primary Care: Clinics in Office Practice

22 March 2024

published in

1 reference

8 August 2017

30

1 reference

8 August 2017

2

1 reference

8 August 2017

441-463

1 reference

Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Caffeine: its effect on catecholamines and metabolism in lean and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Adrenomedullary response to caffeine in prepubertal and pubertal obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Caffeine disposition in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Clinical pharmacokinetics of drugs in obesity. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Coffee consumption, diet, and lipids.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Risk factors for myocardial infarction in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Pharmacological rationale for the clinical use of caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Ephedrine reduces weight of viable yellow obese mice (Avy/a).

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Genetically obese C57BL/6 ob/ob mice respond normally to sympathomimetic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Thermogenic drugs for the treatment of obesity: screening using obese rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effects of ephedrine and atenolol on the development of obesity and diabetes in ob/ob mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Enhanced thermogenic responsiveness during chronic ephedrine treatment in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose-induced thermogenesis in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Pharmacology of thermogenic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Combined drug treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Pharmaceutical cost savings of treating obesity with weight loss medications

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Medicating the obese patient

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Present and future pharmacological approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Current concepts in the pharmacological management of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Current and potential drugs for treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Drug treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Pharmacological and clinical studies of ephedrine and other thermogenic agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Coffee and tea intake and the risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Catechol O-methyltransferase. 5. Structure-activity relations for inhibition by flavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Anti-obesity action of oolong tea

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by Delta(9)-desaturase.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid (CLA) content of milk from cows offered diets rich in linoleic and linolenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid and disease prevention: a review of current knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid and the control of cancer and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effect of conjugated linoleic acid on body composition in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Dietary effect of conjugated linoleic acid on lipid levels in white adipose tissue of Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Conjugated linoleic acid inhibits proliferation but stimulates lipid filling of murine 3T3-L1 preadipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Metabolic regulation as a control for lipid disorders. I. Influence of (—)-hydroxycitrate on experimentally induced obesity in the rodent

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

(-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Dietary fiber and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effects of dietary fiber intake before meals on weight loss and hunger in a weight-reducing club.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Effect of one week of fibre supplementation on hunger and satiety ratings and energy intake

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

The therapeutic effect of fiber in treating obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

The effectiveness of long-term fibre supplementation on weight maintenance in weight-reduced women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Dietary fat, sugar, and fiber predict body fat content

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Fiber intake of normal weight, moderately obese and severely obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Decrease in serum LDL cholesterol with microcrystalline chitosan

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Randomized, double-blind trial of chitosan for body weight reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Comparative evaluation of fecal fat excretion induced by orlistat and chitosan

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900015-0

7 January 2021

Advances in our understanding of the role of the sympathetic nervous system in obesity

9

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Changes in plasma cortisol, glucose and free fatty acids after caffeine ingestion in obese women

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Coffee induced thermogenesis and skin temperature

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Caffeine pharmacokinetics in obesity and following significant weight reduction

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Ephedrine, a thermogenic and potential slimming drug

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans

22 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors

22 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Thermogenic agents in the treatment of human obesity: preliminary results

22 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Does ephedrine promote weight loss in low-energy-adapted obese women?

22 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effect of physical training on thermogenic responses to cold and ephedrine in obesity

22 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial

22 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans

22 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man

22 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity

22 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet

22 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effects of ephedrine and aminophylline on resting energy expenditure in obese adolescents

22 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice

22 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis

22 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Ephedrine and weight loss

22 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effect of spiced food on metabolic rate

22 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse

22 March 2024

86

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake

22 March 2024

87

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Effect of glucomannan on obese patients: a clinical study

22 March 2024

99

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Overweight treated with energy restriction and a dietary fibre supplement: a 6-month randomized, double-blind, placebo-controlled trial

22 March 2024

106

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial

22 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

Dietary fiber added to a very-low caloric diet reduces hunger and alleviates constipation

22 March 2024

111

1 reference

https://api.crossref.org/works/10.1016/S0095-4543(03)00015-0

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference